The latest addition to the Evidence family of immunoassay analysers, the
Evidence Evolution, is the world’s first fully automated random access biochip testing platform.
The Evidence Evolution is set to revolutionise current diagnostic testing as the first of its kind to offer complete system integration, with the most comprehensive test menu on the market. Utilising proven and perfected multiplex Biochip Array Technology, the Evidence Evolution is capable of testing for multiple analytes simultaneously from a single sample, providing advanced test consolidation and patient profiling.
True onboard random access, state of the art intuitive E-Touch software and advanced precision Bio-drive robotics are but a few of the features the Evidence Evolution can offer.
Fully automated, processing in excess of 2940 tests per hour, and with an industry leading test menu available, the Evidence Evolution is setting new standards in clinical diagnostic testing.